Article
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
26 May 2010
Abstract excerpt
No abstract is available from the source.
Loading publication...
Back to search
Community interpretation
Discuss the evidence
Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.
0
discussions
0
replies
Citations encouraged
Claims remain attributable.
No discussion yet
Be the first to add a careful, cited interpretation.